(19)
(11) EP 1 121 371 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
02.09.2009 Bulletin 2009/36

(45) Mention of the grant of the patent:
27.05.2009 Bulletin 2009/22

(21) Application number: 99930140.1

(22) Date of filing: 02.06.1999
(51) International Patent Classification (IPC): 
C07H 19/06(2006.01)
C07H 21/00(2006.01)
C12Q 1/68(2006.01)
 C07H 19/16(2006.01)
C07H 19/20(2006.01)
(86) International application number:
PCT/US1999/012323
(87) International publication number:
WO 2000/021974 (20.04.2000 Gazette 2000/16)

(54)

NUCLEOTIDE COMPOUNDS INCLUDING A RIGID LINKER

EINEN STARREN LINKER ENTHALTENDE NUKLEOTIDE

COMPOSES NUCLEOTIDIQUES COMPRENANT UNE LIAISON RIGIDE

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 14.10.1998 US 172789

(43) Date of publication of application:
08.08.2001 Bulletin 2001/32

(60) Divisional application:
09006976.6

(73) Proprietor: Applied Biosystems, LLC
Carlsbad, CA 92008 (US)

(72) Inventors:
  • KAHN, Shaheer, H.
    Foster City, CA 94404 (US)
  • ROSENBLUM, Barnett, B.
    San Jose, CA 95118 (US)
  • ZHEN, Weiguo
    Foster City, CA 94404 (US)
  • MENCHEN, Steven, M.
    Fremont, CA 94536 (US)

(74) Representative: Grund, Martin 
GRUND Intellectual Property Group Postfach 44 05 16
80754 München
80754 München (DE)


(56) References cited: : 
EP-A- 0 710 667
US-A- 5 770 716
 US-A- 5 151 507
US-A- 5 948 648
   
  • PROBER J M ET AL: "A SYSTEM FOR RAPID DNA SEQUENCING WITH FLUORESCENT CHAIN- TERMINATING DIDEOXYNUCLEOTIDES" , SCIENCE,US,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, VOL. 238, NR. 4825, PAGE(S) 336-341 XP000604017 ISSN: 0036-8075 cited in the application page 336, left-hand column, paragraph 4 -right-hand column, paragraph 2 figure 2
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).